Published February 8, 2018 | Version Published + Supplemental Material
Journal Article Open

Non-Invasive Electrical Impedance Tomography for Multi-Scale Detection of Liver Fat Content

Abstract

Introduction: Obesity is associated with an increased risk of nonalcoholic fatty liver disease (NAFLD). While Magnetic Resonance Imaging (MRI) is a non-invasive gold standard to detect fatty liver, we demonstrate a low-cost and portable electrical impedance tomography (EIT) approach with circumferential abdominal electrodes for liver conductivity measurements. Methods and Results: A finite element model (FEM) was established to simulate decremental liver conductivity in response to incremental liver lipid content. To validate the FEM simulation, we performed EIT imaging on an ex vivo porcine liver in a non-conductive tank with 32 circumferentially-embedded electrodes, demonstrating a high-resolution output given a priori information on location and geometry. To further examine EIT capacity in fatty liver detection, we performed EIT measurements in age- and gender-matched New Zealand White rabbits (3 on normal, 3 on high-fat diets). Liver conductivity values were significantly distinct following the high-fat diet (p = 0.003 vs. normal diet, n=3), accompanied by histopathological evidence of hepatic fat accumulation. We further assessed EIT imaging in human subjects with MRI quantification for fat volume fraction based on Dixon procedures, demonstrating average liver conductivity of 0.331 S/m for subjects with low Body-Mass Index (BMI < 25 kg/m²) and 0.286 S/m for high BMI (> 25 kg/m²). Conclusion: We provide both the theoretical and experimental framework for a multi-scale EIT strategy to detect liver lipid content. Our preliminary studies pave the way to enhance the spatial resolution of EIT as a marker for fatty liver disease and metabolic syndrome.

Additional Information

© 2018 Ivyspring International Publisher. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). Received 2017-8-4; Accepted 2017-12-1; Published 2018-2-8. This study was supported by NIH R01HL083015 (T.K.H.), R01HL118650 (T.K.H.), R01HL111437 (T.K.H.), U54 EB0220002 (T.K.H., A.B.), R01NR014669 (M.W. and R.K.), American Heart Association 16SDG30910007 (R.R.S.P.), UCLA MSTP program (P.A.), and UCLA David Geffen Scholarship (P.A.). The authors have declared that no competing interest exists.

Attached Files

Published - v08p1636.pdf

Supplemental Material - thnov08p1636s1.pdf

Files

thnov08p1636s1.pdf

Files (2.6 MB)

Name Size
md5:f8b1b78c16936660eb6b71416bca96fd
308.5 kB Preview Download
md5:cc3bedf4bf848c52fa747a51f71fbab6
2.3 MB Preview Download

Additional details

Identifiers

PMCID
PMC5858172
Eprint ID
84917
Resolver ID
CaltechAUTHORS:20180222-083518129

Funding

NIH
R01HL083015
NIH
R01HL118650
NIH
R01HL111437
NIH
U54 EB0220002
NIH
R01NR014669
American Heart Association
16SDG30910007
UCLA-Caltech Medical Scientist Training Program

Dates

Created
2018-02-22
Created from EPrint's datestamp field
Updated
2021-11-15
Created from EPrint's last_modified field